BiotechTube

Perampanel + Perampanel

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Seizures

Conditions

Seizures

Trial Timeline

Jan 21, 2020 → Mar 31, 2023

NCT ID
NCT04202159

About Perampanel + Perampanel

Perampanel + Perampanel is a pre-clinical stage product being developed by Eisai for Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT04202159. Target conditions include Seizures.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (8)

NCT IDPhaseStatus
NCT04202159Pre-clinicalCompleted
NCT03754582Phase 2Completed
NCT03399734Phase 1Completed
NCT03376997Phase 1Completed
NCT02020486Phase 1Completed
NCT01396577Phase 1Completed
NCT01396590Phase 1Completed
NCT01240187Phase 1Completed

Competing Products

20 competing products in Seizures

See all competitors
ProductCompanyStageHype Score
E2007EisaiPhase 3
77
PerampanelEisaiPre-clinical
23
perampanel + perampanel + perampanel + PlaceboEisaiPhase 3
77
perampanelEisaiPhase 2
52
PerampanelEisaiPre-clinical
23
Zonisamide + PlaceboEisaiPhase 3
77
zonisamideEisaiPre-clinical
23
E2007 (perampanel) + E2007 (perampanel) + PlaceboEisaiPhase 3
77
Perampanel + PlaceboEisaiPhase 3
77
E2007 (perampanel) + E2007 (perampanel) + PlaceboEisaiPhase 3
77
Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved
85
FycompaEisaiPre-clinical
23
Zonisamide + PlaceboEisaiPhase 3
77
FycompaEisaiPre-clinical
23
RufinamideEisaiPhase 3
77
Eslicarbazepine Acetate tabletsEisaiPre-clinical
23
PerampanelEisaiPre-clinical
23
PerampanelEisaiPre-clinical
23
PerampanelEisaiApproved
85
Zonisamide tabletsEisaiPre-clinical
23

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85